AU2258601A - Ibd-related polymorphisms - Google Patents

Ibd-related polymorphisms

Info

Publication number: AU2258601A
Authority: AU; Australia
Prior art keywords: ibd; related polymorphisms; polymorphisms
Prior art date: 1999-12-10
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU22586/01A

Inventor

Mark Daly

Thomas J. Hudson

Eric S. Lander

John Rioux

Kathy Siminovitch

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Ellipsis Biotherapeutics Corp

Whitehead Institute for Biomedical Research

Original Assignee

Ellipsis Biotherapeutics Corp

Whitehead Institute for Biomedical Research

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-12-10

Filing date

2000-12-11

Publication date

2001-06-18

2000-12-11 Application filed by Ellipsis Biotherapeutics Corp, Whitehead Institute for Biomedical Research filed Critical Ellipsis Biotherapeutics Corp

2001-06-18 Publication of AU2258601A publication Critical patent/AU2258601A/en

Status Abandoned legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6827—Hybridisation assays for detection of mutation or polymorphism
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/172—Haplotypes

Landscapes

Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Zoology (AREA)
Wood Science & Technology (AREA)
Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Analytical Chemistry (AREA)
Microbiology (AREA)
Immunology (AREA)
Molecular Biology (AREA)
Biotechnology (AREA)
Biophysics (AREA)
Physics & Mathematics (AREA)
Biochemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
General Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Genetics & Genomics (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

AU22586/01A 1999-12-10 2000-12-11 Ibd-related polymorphisms Abandoned AU2258601A (en)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
US17025799P	1999-12-10	1999-12-10
US60170257		1999-12-10
US19604600P	2000-04-10	2000-04-10
US60196046		2000-04-10
PCT/US2000/033632 WO2001042511A2 (en)	1999-12-10	2000-12-11	Ibd-related polymorphisms

Publications (1)

Publication Number	Publication Date
AU2258601A true AU2258601A (en)	2001-06-18

Family

ID=26865891

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU22586/01A Abandoned AU2258601A (en)	1999-12-10	2000-12-11	Ibd-related polymorphisms

Country Status (4)

Country	Link
EP (1)	EP1276899A2 (en)
AU (1)	AU2258601A (en)
CA (1)	CA2394033A1 (en)
WO (1)	WO2001042511A2 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1169440A4 (en) *	1999-03-23	2004-01-14	Human Genome Sciences Inc	48 human secreted proteins
AU2002348745A1 (en) *	2001-12-21	2003-07-09	Ellipsis Biotherapeutics Corporation	Polymorphisms of the OCTN1 and OCTN2 cation transporters associated with inflammatory bowel disease
US20110229471A1 (en)	2008-11-26	2011-09-22	Cedars-Sinai Medical Center	Methods of determining responsiveness to anti-tnf alpha therapy in inflammatory bowel disease
KR102343212B1 (en)	2013-03-27	2021-12-23	세다르스-신나이 메디칼 센터	Mitigation and reversal of fibrosis and inflammation by inhibition of tl1a function and related signaling pathways
US10316083B2 (en)	2013-07-19	2019-06-11	Cedars-Sinai Medical Center	Signature of TL1A (TNFSF15) signaling pathway
KR20180127416A (en)	2016-03-17	2018-11-28	세다르스-신나이 메디칼 센터	Diagnosis of Inflammatory Bowel Disease through RNASET2
CN108359736B (en) *	2018-05-23	2020-12-29	华中农业大学	SNP genetic marker for sow limb hoof bone density character

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
HU208711B (en) *	1984-07-06	1993-12-28	Sandoz Ag	Method for preparing gm-csf and transformation vector containing csf/cdna, also a methold for purifying the csf protein
WO1994004196A1 (en) *	1992-08-14	1994-03-03	Imperial Cancer Research Technology Limited	Tumour therapy
US5681699A (en) *	1994-02-11	1997-10-28	Cedars-Sinai Medical Center	Methods of diagnosing ulcerative colitis and Crohn's disease
US5916748A (en) *	1996-04-12	1999-06-29	Cedars-Sinai Medical Center	Method of diagnosing a clinical subtype of crohn's disease with features of ulcerative colitis
WO1998020165A2 (en) *	1996-11-06	1998-05-14	Whitehead Institute For Biomedical Research	Biallelic markers
JP2002512511A (en) *	1997-03-07	2002-04-23	アフィメトリックス，インコーポレイテッド	Gene compositions and methods

2000
- 2000-12-11 CA CA002394033A patent/CA2394033A1/en not_active Abandoned
- 2000-12-11 WO PCT/US2000/033632 patent/WO2001042511A2/en not_active Application Discontinuation
- 2000-12-11 EP EP00986325A patent/EP1276899A2/en not_active Withdrawn
- 2000-12-11 AU AU22586/01A patent/AU2258601A/en not_active Abandoned

Also Published As

Publication number	Publication date
CA2394033A1 (en)	2001-06-14
WO2001042511A3 (en)	2002-11-14
WO2001042511A2 (en)	2001-06-14
EP1276899A2 (en)	2003-01-22

Publication	Publication Date	Title
AU1173201A (en)	2001-05-14	Skin-gripper
AU3092999A (en)	2000-10-04	Digital-timeshare-exchange
AU5967600A (en)	2001-02-13	Candystraw
AU7514700A (en)	2001-04-10	Cyanopiperidines
AU4115400A (en)	2000-11-14	Short-circuiter
AU6335000A (en)	2001-04-24	Depthimeter
AU2023701A (en)	2001-06-18	Sketcher
AU6440900A (en)	2001-03-13	Homogentisate-dioxygenase
AU2804600A (en)	2000-09-04	Arylaminoalkylamides
AU6098300A (en)	2001-02-05	Follistatin-3
AU4916900A (en)	2000-12-05	Benzofuranylsulfonates
AU2258601A (en)	2001-06-18	Ibd-related polymorphisms
AU4561600A (en)	2000-12-05	Benzofuranylaminoalcohols
AU1901801A (en)	2001-05-30	Glucofuranoses
AU7513400A (en)	2001-04-30	Hydantoin-racemase
AU2582200A (en)	2000-09-14	Windturbine
AU4435300A (en)	2000-11-10	Hula-hoop
AU1915601A (en)	2001-06-06	Periotome
AU1404901A (en)	2001-05-30	Cd36 polymorphisms
AU5416100A (en)	2001-01-31	Retinoscopes
AU2197301A (en)	2001-06-25	Microlamp
AU5487300A (en)	2001-01-02	Benzylpiperazinyl-indolinylethanones
AU1737601A (en)	2001-05-08	Collectalbum
AU6403100A (en)	2001-01-02	Earphone-speaker
AU2374501A (en)	2001-06-18	Thermoroll

Legal Events

Date	Code	Title	Description
2002-08-15	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase